NTRA Stock Analysis: Buy, Sell, or Hold?
NTRA - Natera, Inc. Common Stock
$194.24
-25.58 (-11.64%)
▼
5d:
-6.29%
30d:
-4.32%
90d:
-4.33%
HOLD
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
NTRA is down 6.3% this week, but smart money is accumulating calls. Top strike: $220 2026-07-17 with 3,168 OI. Call ratio: 90% View Scanner →
Strength: 7.1/10
Get Alerted When NTRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NTRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NTRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NTRA is currently trading at $194.24, which is considered oversold relative to its 30-day fair value range of $197.62 to $211.57.
Technical Outlook: Technically, NTRA is in a strong downtrend. The price is currently testing key support at $189.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.6% recently.
Market Sentiment: NTRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $258.00 (+32.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTRA is in a strong downtrend. The price is currently testing key support at $189.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.6% recently.
Market Sentiment: NTRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $258.00 (+32.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$197.62 -
$211.57
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
89.5%
Protect Your Profits
Holding NTRA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.6%)
- BULLISH: Trading 32.8% below Wall St target ($258.00)
- CAUTION: Recommendation downgraded due to -6.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$197.62 -
$211.57
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$189.53
Resistance Level
$221.56
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-286.36
Wall Street Target
$258.00
(+32.8%)
Revenue Growth (YoY)
39.8%
Profit Margin
-9.0%
Share & Embed Analysis
Last updated: May 10, 2026 11:51 AM ET
Data refreshes hourly during market hours. Next update: 12:51 PM
Data refreshes hourly during market hours. Next update: 12:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Solomon Moshkevich
SELL
3000 shares
2026-04-01
Rowan E Chapman
SELL
122 shares
2026-03-13
John Fesko
SELL
707 shares
2026-03-10
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$620 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 55 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$130 | 62 BUY |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$229 | 65 BUY |
Advanced NTRA Option Strategies
Professional options setups generated by AI based on today's NTRA price and gamma walls.
